This is the authors' abstract. We don't add key points for this paper.
Under a wide range of assumptions, for a 65-year-old man, active surveillance is a reasonable approach to low-risk prostate cancer based on QALE compared with initial treatment. However, individual preferences play a central role in the decision whether to treat or to pursue active surveillance.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hayes et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: